Biotechnology in Korea is growing fast as a core industrial technology which is able to create the national resources in the 21st century, and the government has recently selected biotechnology as a growth power technology and concentrated the effort to secure international competitiveness in biotechnology area through nation-wide investment and support. In Korea Research Institute of Bioscience & Biotechnology (KRIBB), which is the only government-funded life science research institute, has been established in 1985, and successfully operating in both technology transfer and spin-off by accomplishing the annual out-licensing contract fee of USD 35 million in 2009, and 6 companies out of total 23 spin-offs were listed in stock market. Once the IP or technology is ready for market, KRIBB TLO(Technology Licensing Office) determines whether to create out-licensing, joint-venture, and spin-off by the consideration of scientific value, market situation and business opportunity for the IP or technology. This presentation introduces the detailed examples of a KRIBB’s experience and strategy for successful technology commercialization including out-licensing, joint-venture and spin-off.
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동